← back to search

François Danion

Université de Caen Normandie · FR
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include COVID-19 Clinical Research Studies, Antifungal resistance and susceptibility, SARS-CoV-2 and COVID-19 Research, and Fungal Infections and Studies.
h-index
30
citations
4,820
works
140
NIH funding
primary concept
Medicine
email

Recent publications

Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study
Clinical Microbiology and Infection 2024cited by 57position: middledoi
Real-world multicentre study of cefiderocol treatment of immunocompromised patients with infections caused by multidrug-resistant Gram-negative bacteria: CEFI-ID
Journal of Infection 2024cited by 28position: middledoi
Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study
The Lancet Infectious Diseases 2023cited by 134position: middledoi
Improving Diagnosis of Pulmonary Mucormycosis
CHEST Journal 2023cited by 29position: middledoi
Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study
Mycopathologia 2023cited by 27position: middledoi
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial
The Lancet 2022cited by 165position: middledoi
Outcome of infection with omicron <scp>SARS‐CoV</scp>‐2 variant in patients with hematological malignancies: An <scp>EPICOVIDEHA</scp> survey report
American Journal of Hematology 2022cited by 72position: middledoi
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19
The Lancet Infectious Diseases 2022cited by 20position: middledoi
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
The Lancet Infectious Diseases 2021cited by 343position: middledoi
Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort
Science Translational Medicine 2021cited by 124position: middledoi
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19
Clinical Microbiology and Infection 2021cited by 107position: middledoi
Cerebral aspergillosis in the era of new antifungals: The CEREALS national cohort study Nationwide CEREbral Aspergillosis Lesional study (CEREALS)
Journal of Infection 2021cited by 22position: middledoi
Is COVID-19 infection more severe in kidney transplant recipients?
American Journal of Transplantation 2020cited by 264position: lastdoi
Spectrum of Pulmonary Aspergillosis in Hyper-IgE Syndrome with Autosomal-Dominant STAT3 Deficiency
The Journal of Allergy and Clinical Immunology In Practice 2019cited by 39position: middledoi
Non-virological response to a dolutegravir-containing regimen in a patient harbouring a E157Q-mutated virus in the integrase region
Journal of Antimicrobial Chemotherapy 2015cited by 23position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2024–2024) · 1 papers (2024–2024) · 1 papers (2024–2024) · 1 papers (2024–2024) · 1 papers (2024–2024)Guillaume Martin‐Blondel · Centre National de la Recherche Scientifique1 papers (2024–2024) · 1 papers (2024–2024)Claudine Duvivier · Hôpital Necker-Enfants Malades1 papers (2015–2015)Emmanuel Faure · Unité de Glycobiologie Structurale et Fonctionnelle1 papers (2024–2024) · 1 papers (2024–2024)Véronique Avettand-Fènoël · Institut Pasteur1 papers (2015–2015)Émilie Belissa · Université Claude Bernard Lyon 11 papers (2015–2015)Oana Dumitrescu · Université Claude Bernard Lyon 11 papers (2024–2024) · 1 papers (2024–2024)Anne Huynh · Dartmouth–Hitchcock Medical Center1 papers (2024–2024) · 1 papers (2015–2015) · 1 papers (2015–2015) · 1 papers (2024–2024)Benjamin Gaborit · VA Boston Healthcare System1 papers (2024–2024)Florence Ader · Unité de recherche sur les maladies cardiovasculaires et métaboliques1 papers (2024–2024)